ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Laboratorios Silanes S.A. de C.V. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 56 studies whose lead sponsor is Laboratorios Silanes S.A. de C.V. or the company grouped under it. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 28, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Laboratorios Silanes S.A. de C.V. with Swedish Orphan Biovitrum and Innovent Biologics →

Pipeline: 8 programs

Each counted once: 8 with a study Laboratorios Silanes S.A. de C.V. leads registered in the last two years.

  • Phase 1
  • Phase 3

The 5 of 6 with the most live studies.

Program
EtoricoxibMK0663Phase 3 · 1 live · Osteoarthritis · primary completion Dec 2026☆ Track
AcetaminophenPhase 3 · 0 live · Pain☆ Track
CelecoxibDFN15Phase 3 · 0 live · Osteoarthritis☆ Track
dexketoprofenPhase 3 · 0 live · Acute Pain☆ Track
BetamethasonePhase 3 · 0 live · Psoriasis☆ Track

1 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Laboratorios Silanes S.A. de C.V.’s own registered studies; Laboratorios Silanes S.A. de C.V.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Laboratorios Silanes S.A. de C.V.’s studies test, most studies first; none is open now — 18 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Show 8 more

Coming up

1 of Laboratorios Silanes S.A. de C.V.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 20, 2026.

All 56 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now12%
  • Completed4784%
  • Stopped early47%Suspended 2 · Terminated 1 · Withdrawn 1
  • Status unknown or other47%

Phase

  • Phase 327
  • Phase 115
  • Phase 212
  • Phase 43

Where

  • Mexico46
  • United States8
  • Spain1
  • Morocco1

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 721
  16. 22
  17. 23
  18. 24
  19. 25
  20. 026

By the year each study started; 7 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Laboratorios Silanes S.A. de C.V.

  • Laboratorios Silanes S.A. de C.V.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    45 studies
  • Instituto Bioclon S.A. de C.V.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies →

Studies

Recruiting first, then most recently updated. Showing 50 of 56. Browse all 56 →